Le Lézard
Classified in: Health, Business, Sports and recreation
Subject: SRI

Phoenix Foundation of Maryland 2nd Annual Recovery Education Classic Golf Tournament


MYERSVILLE, Md., Feb. 28, 2020 /PRNewswire-PRWeb/ -- On Friday, April 17, the Phoenix Foundation of Maryland, a Frederick based non-profit, will host the 2nd Annual Recovery Education Classic Golf Tournament. The Phoenix Foundation of Maryland will establish a state-recognized recovery high school for individuals who struggle with alcohol and drug abuse in Frederick, MD.

The golf tournament will host keynote speakers, lunch, 50/50 raffle, and many other contests, all to benefit the Phoenix Foundation of Maryland. The money raised will go directly towards the mission of opening up a recovery high school in Frederick, MD in August 2020 in downtown Frederick. Your sponsorship dollars are an investment in our community!

The public is encouraged to attend this event. For more information about the event, connect with Phoenix Foundation of Maryland on Facebook and Instagram.

To schedule interviews leading up to the event and day of the event, contact Heather Whitcomb of Phoenix Foundation of Maryland, [email protected].

To sponsor or register to play, visit: http://www.musketridge.com/phoenix

About the Phoenix Foundation of MD
The Phoenix Foundation of Maryland will establish a state-recognized recovery high school for individuals who struggle with alcohol and drug abuse in Frederick, MD at 117 E. Church St., Frederick, MD in August 2020. http://www.phoenixfoundationmd.org

 

SOURCE Phoenix Foundation of Maryland


These press releases may also interest you

at 00:05
ImmunityBio Announces Positive Overall Survival Results of Anktiva Combined With Checkpoint Inhibitors in Non-Small Cell Lung Cancer; Meeting Scheduled with FDA to Discuss Registration Path for ANKTIVA in Lung Cancer
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
Few small SUVs excel in new IIHS front crash prevention test
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential expands globally to Oceania, Asia and the Gulf
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research Statement on Co-Founder and Chairman Dr. Stephen Harrison
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Junshi Biosciences Announces NDA Acceptance in Hong Kong for Toripalimab
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

More news about Health...


News published on and distributed by: